Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- Paclitaxel-Based Chemoradiotherapy in the Treatment of Patients With Operable Esophageal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Esophageal Cancer Clinical Practice GuidelinesJournal of the National Comprehensive Cancer Network, 2006
- Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative ChemoradiationJournal of Clinical Oncology, 2006
- Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete responseCancer, 2005
- Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its ComplicationsAnnals of Internal Medicine, 2005
- Chemoradiotherapy of Locally Advanced Esophageal CancerJAMA, 1999
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI: Journal of the National Cancer Institute, 1994